Drugs / Interferon-beta1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00473213 | Sep 1999 → Feb 2004 | multiple sclerosis | University of Turin, Italy | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04079088 Background | Jun 2021 → Sep 2024 | multiple sclerosis | Biogen | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon-beta1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04079088 ↗ |
| Route | Subcutaneous | “s.c. every other day” PMID 19278300 ↗ Apr 2009 |